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Abstract 
Two microsatellites from corticotropin
releasing hormone (CRH) gene locus
(CRHRA1 and CRHRA2) were reported to be
associated with rheumatoid arthritis (RA) in
Caucasians. This study aims to replicate the
association in a South Asian (SA) and
Caucasian RA sample from the East Midlands,
UK. DNA from 281 South Asians (111 patients,
43 siblings, 127 controls) and 287 Caucasians
(116 patients, 64 siblings, 107 controls)  were
genotyped. The Odds Ratio for carrying at least
one copy of the CRHRA1*10 risk allele was 1.32
(Confidence Interval, CI=0.77-2.28) in
Caucasians and 1.55 (CI=0.92-2.63) in South
Asians, indicative of a trend for association.
The risk allele CRHRA2*14 was lower in South
Asians compared to Caucasians (5.5-8.6% vs.
17.7-18.2%; P<0.005). Significant linkage dise-
quilibrium was observed between CRHRA1 and
CRHRA2 in both cohorts. CRHRA1*10 was the
frequently transmitted allele in SA patients. A
non-significant association was observed with
CRHRA1*10 allele in both RA populations. 
Introduction
Rheumatoid arthritis (RA) is a common
autoimmune disease in which both environ-
mental and genetic factors seem to play a role
in the inception, progression, severity and
episodic nature of the disease. Genome-wide
and candidate association studies have sug-
gested many genetic susceptibility loci, but
HLA-DR, and more recently PTPN22, PADI4
and CTLA4, remain the validated genetic mark-
ers for RA.1,2 Panayi reported that RA is multi-
factorial and may be complicated by non HLA
factors such as the neuroendocrine hormone,
the corticotropin releasing hormone (CRH).3
The hormone is released from hypothalamus
under the influence of TNFα, IL-1β and IL-6.  
Centrally, CRH releases pituitary adrenocor-
ticotropin, which in turn stimulates the adre-
nal cortex to release cortisol from the adrenal
gland. The amount of cortisol released is
reduced in RA patients.4 Lewis rats, which are
susceptible to RA induction, also have low cor-
tisol levels. Locally, the CRH levels are
increased in the joints of experimental arthri-
tis (in Lewis rats) and in the synovium and
synovial fluid of RA patients.5,6 In situ CRH
increases the cycloxygenase-2 derived
prostaglandins E2 and E1 locally, thus promot-
ing joint disease progression7 and pain percep-
tion.8
Baerwald et al. (2000)9 studied the genetic
polymorphisms in the promoter region of the
CRH gene among Caucasian (UK) and South
African black RA patients and found that hap-
lotype A2B1 was protective against developing
RA in UK patients whereas allele A1B1 was
positively associated with RA in the black
South African RA patients (OR=1.78; CI= 1.01-
3.15). Gonzalez-Gay et al.10 found that CRH-A2
allele was significantly increased only in the
late onset sero-negative RA patients from the
Lugo region of Spain.
Fife et al.11 investigated short tandem repeat
(STR)/microsatellite genetic variation at
CRHRA1 (8q12.3) in 295 Caucasian families
and  found a significant excess of allele shar-
ing in affected members and significant link-
age over a 22 cM region between markers
D8S285 and D8S530. A further STR located 20
kb downstream of the CRH structural gene
named CRHRA2 also showed strong linkage
disequilibrium with CRHRA1.12 Fife and col-
leagues reported that the haplotype
(CHRA1*10 - CRHRA2*14) was associated
with RA in 131 simplex Caucasian families.12
In a Spanish study (121 simplex RA families
and 101 healthy controls) significant linkage
disequilibrium between the two loci was
observed but there was no association of any
alleles or haplotypes with RA.13 The haplotype
RA1*10 - RA2*14 was found to be under-trans-
mitted in the study (12 observed versus 17.43
expected). 
Previous studies have shown interesting
genetic variation in Caucasian and other eth-
nic populations9 but no studies have examined
CRH microsatellite variation in South Asian
RA patients. The increased production of PGE1
due to polymorphic CRH, with subsequent
hypersensitisation of the pain nerve endings,
may be associated to the differing pain percep-
tion in the two ethnic groups as some studies
on South Asians have reported lower pain
thresholds in RA. This difference in pain may
be readily reflected in the severity of self
assessed RA. The aim of this study was to
determine if the two STRs (CRHRA1 and
CRHRA2) are associated with RA in South
Asian and Caucasian populations of the East
Midlands.
Materials and Methods 
Subsequent to the approvals by local ethical
committees and written consent according to
the 1996 Declaration of Helsinki, DNA samples
were obtained and genotyped from 111 South
Asian Patients, 43 South Asian siblings, 127
South Asian controls, 111 Caucasian Patients ,
64 Caucasian  siblings  and 107 Caucasian
control. Genotyping for the two CRH micro -
satellite markers was performed as described
by Fife et al.12 in the presence of fluorescently
labelled  primers (CRHRA1 - (F) 5’-FAM CCC
AGT CCC CAT GAT ATC AG -3’, (R) 5’-AAC TTT
CCC ACC AGT AAT GCC-3’ and CRHRA2 - (F)
5’-HEX CAG TTT CCT TGG GCT TCT ACA G -3’,
(R) 5’-AAG TCC CTA TCT CCA AAG CAA T-3’).   
Allele and genotype frequencies were com-
pared between cases and controls using chi-
squared statistics and odds ratios were calcu-
lated by Woolf’s method. Family based associa-
tion analysis was carried out using Sib-TDT14
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which tests for association by comparing
marker allele frequencies between affected
and unaffected siblings which differ in geno-
type. Haplotype frequencies and linkage dise-
quilibrium between microsatellites were esti-
mated using EHPLUS program.15
A questionnaire was used to assess self per-
ception of severity, pain and quality of life.
Patients were asked to score three categories
for pain and severity in a simple questionnaire
as to how they perceived their pain due to RA -
Mild, Moderate or Severe.  The gradations of
the duration of disease, self assessed severity
and pain were assessed by two-way association
analysis using cross-tab (contingency Table)
method on SPSS against the CRH genotypes. 
Results
Both microsatellites analysed at the CRH
locus (CRHRA1 and CRHRA2) showed wide
genetic variation. At CRHRA1 locus, 7 geno-
types (8,10; 9,10; 9, 11; 10, 10; 10,11; 11,11; and
11, 12) accounted for more than 90% of the
genotypic variation observed in various group-
ings of patients and controls. Two genotypes
(10, 11 and 11, 11) were most frequent in all
groups accounting for 30 to 60% of genotypic
distribution. Asian groups showed slightly
higher frequency of these genotypes (60-61%)
compared to Caucasians (30-59%). All the four
groups (SA Patients and controls; Caucasian
Patients and controls) were in Hardy-
Weinberg equilibrium. Two alleles CRHRA1*10
and CRHRA1*11 accounted for majority of the
genetic variation at this locus (Table 1). The
risk allele CRHRA1*10 was higher in cases
than controls in both populations but the dif-
ferences were statistically not significant
(P=0.11). 
At the CRHRA2 locus, 71 different genotypes
were detected in various groups, though not all
genotypes were observed in all groups. Two
genotypes (12, 13 and 12, 14) accounted for 10
to 18% of the frequency variation. The risk
allele CRHRA2*14 frequency was slightly high-
er in South Asian RA compared to controls
(8.6% vs 5.5%). The frequency of CRHRA2*11
was observed to be significantly higher in
South Asian RAs (9.90 % versus 3.1%, P<0.05).
CRHRA2*14 was rare in South Asians (5.5%
versus. 18.2 %; P = 0.005).  When Bonferroni
correction (P=0.003) for multiple comparisons
was applied these differences became non-
significant. Association analysis
CRHRA1 and CRHRA2 genotypes were in
Hardy Weinberg equilibrium in cases and con-
trols in both populations. Two alleles
(CRHRA1*10 and *11) accounted for approxi-
mately 80% of the genetic variation at CRHRA1
(Table 1). In the South Asian cohort, the previ-
ously defined risk allele CRHRA1*10 occurred
at a higher frequency in cases (34.3%) than
controls (26.9%) although this difference did
not reach statistical significance (P=0.11).
The frequency of this allele was also slightly
higher in Caucasian cases (26.6%) compared
with controls (23.5%) (P=0.54). In the Asian
cohort, the odds ratio associated with presence
(at least one copy) of CRHRA1*10 was 1.55
(95% CI 0.92 – 2.63), compared with an odds
ratio of 1.32 (95% CI 0.77-2.28) in the
Caucasian cohort.
There was no significant difference in the
frequency of CRHRA2*14 between either
Caucasian cases (17.7%) and controls (18.2%,
P=0.71), or between South Asian cases (8.6%)
and controls (5.5%, P=0.26). Interestingly, this
allele occurred at significantly lower frequency
in the South Asian than Caucasian controls
(P=3.0¥10–5). We did, however, observe a sig-
nificant increase in the frequency of
CRHRA2*11 in South Asian cases (9.9%) than
controls (3.1%) (P=0.0045), though after mul-
tiple comparison correction, it became no-sig-
nificant.Linkage disequilibrium analysis
Haplotype frequencies were estimated in
218 South Asians (102 RA Patients and 116
Random Controls) and 208 Caucasians (109
RA Patients and 99 Random Controls) using
Article
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Table 1. CRHRA1 and CRHRA2 allele frequencies in two rheumatoid arthritis populations. 
Allele frequencies (%)
STR CRHRA1 CRHRA2
Group South Asian Caucasian South Asian Caucasian
Allele number RA Controls RA Controls RA Controls RA Controls 
(n=105) (n=119) (n=111) (n=100) (n=111) (n=127) (n=116) (n=107)
3 0 0.4 0 0
4 4.5 6.3 1.7 2.3
5 0 0 0.5 0 0 1.6 0.9 0.5
6 0 0 0.4 0.9
7 0 0 0 0.5
8 2.4 2.1 3.2 3.5 0 0.4 0 0
9 3.3 4.2 8.6 7.5 1.4 0 0.4 1.4
10 34.3* 26.9 26.6* 23.5 1.4 0 3.9 4.7
11 48.6 53.4 51.8 56 9.9° 3.1 8.6 6.5
12 7.6 7.1 7.7 6.5 20.3 24.4 26.3 26.2
13 2.4 3.8 1.4 2.5 11.3 14.2 12.1 14
14 1 0.8 0.5 0 8.6# 5.5 17.7 18.2
15 0.5 1.7 0 0 15.8 12.2 6 8.9
16 14 15.7 16.8 11.7
17 10.8 9.1 3.9 1.9
18 2.3 4.7 1.3 1.9
19 0 2.4 0 0.5
20 0 0 0 0.5
STR, short tandem repeat; RA, rheumatoid arthritis. *Caucasian Odds Ratio = 1.32, CI 0.77-2.28; South Asians, Odds Ratio =1.55, CI 0.95-2.63; ° P <0.005;  #higher, not significant. 
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EHPLUS.15 Significant LD was observed
between CRHRA1 and CRHRA2 in both ethnic
cohorts (South Asian; P=0.0001 and
Caucasian; P=0.0084). A total of 17 haplotypes
with a frequency of at least 2.5% accounted for
70% of all possible haplotypes (Table 2).  The
previously suggested susceptibility haplotype,
CRHRA1*10-CRHRA2*14,12 occurred at a lower
frequency in Asians compared to Caucasians
in both patients (Asian: 3.0% vs. Caucasian:
11.7%) and controls (Asian: 2.4% vs.
Caucasian: 11.1%). A higher frequency of hap-
lotypes 10-15 and 10-16 was observed in Asian
patients compared to Caucasians patients but
these differences were not significant. The
CRHRA2 locus alleles, and haplotypes based on
both loci did not show any association in both
populations.Sib- transmission disequilibrium test 
A total of 43 South Asian and 64 Caucasian
families with at least one affected and one
unaffected sibling were included in the analy-
sis. In the South Asian cohort, CRHRA1*10
was observed 18 times in RA-affected siblings
compared to an expected value of 14.3
(P=0.10). However, there was no increase in
the frequency of the *10 allele in Caucasian
affected siblings (19 observed compared with
18 expected). There was no excess in the fre-
quency of CRHRA2*14 in affected siblings in
both Caucasian and Asian groups, although
CRHRA2*15 was under-represented in
Caucasian affected (4 observed vs. 10 expect-
ed, P=0.039). 
Only CRHRA2 showed a significant associa-
tion with self reported severity by analogue
scale (χ2=156.4, df = 114, P<0.01) of the dis-
ease in South Asians. The perception of pain
assessed by analogue score followed a similar
pattern to severity of RA. 
Discussion 
In the present study, a non-significant asso-
ciation was observed with CRHRA1*10 in both
populations (Caucasian OR = 1.32, CI 0.77-
2.28, South Asians, OR=1.55, CI 0.95-2.63).
The transmission disequilibrium test (Sib-
TDT) analysis, although limited by small num-
bers, also showed evidence of preferential
transmission of CRHRA1*10 to South Asian RA
cases. Although none of these findings result
in a significant association, it is important to
note that the sample sizes here are small,
resulting in low power to detect a significant
association. Nevertheless, the consistent trend
towards an association with *10 allele in both
case-control and sib-TDT studies suggests that
further research with a larger sample of South
Asians is warranted in order to clarify whether
there is an association with RA. Based on the
observed frequency of CRHRA1*10 in South
Asians, approximately 600 case/control pairs
would be required in order to achieve 80%
power (α=0.05) to detect a significant associ-
ation. There was no association with
CRHRA2*14 in either population, although a
second allele, CRHRA2*11, occurred at higher
frequency in South Asian RA cases compared
to controls P=0.005). The risk haplotype
(CRHRA1*10-CRHRA2*14) reported in the
previous UK study did not show any significant
association in this study, consistent with the
lack of a haplotype association observed in a
Spanish cohort.13 In a genome-wide associa-
tion study of microsatellite markers the CRH
gene region was not associated with RA.16
It may be worth exploring these loci in
future research as there is some evidence that
stress may contribute to the RA pathology.17,18
Corticotropin-releasing hormone encoded by
the CRH gene, is a key integrator of stress
responses, and, as such, CRH gene variation
may contribute to individual differences in
susceptibility to stress-related pathology.19
CRH is the strongest known activator of the
HPA axis, which has been functionally impli-
cated in the regulation of many endocrine
functions such as glucocorticoid release from
the adrenal gland and associated endocrine-
immune responses.19 Stress due to relation-
ship difficulties, bereavement in the family or
forced migration in South Asians may have
had effect on the hypothalamic-pituitary-adre-
nal axis where either the polymorphisms in
the CRH gene or their expression may have
played a part in RA occurrence.  
In a comparison of genotypes with the age,
duration, severity and pain, only CRHRA2
showed a significant association with the
severity in South Asian RAs. This observed
association needs further comment. It may be
due to the localised release of CRH leading to
prostaglandin E1 and E2 release. This would
culminate in inflammation and lowered pain
threshold.7 The CRH levels detected in the syn-
ovial fluid from RA patients, although lower
than in osteoarthritis,20 has the propensity to
increase IL-6,18 from macrophages and
increase its activity after combining with CRH-
binding protein,21 and needs further research
for its role in RA inflammation. 
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